Sugi Predict
/ Targets
/ FAU
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to FAU by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients |
PHASE4 | UNKNOWN |
| A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF) |
PHASE3 | COMPLETED |
| Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations |
PHASE3 | RECRUITING |
| A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers |
PHASE2 | COMPLETED |
| Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma |
PHASE2 | UNKNOWN |
| Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver |
PHASE2 | UNKNOWN |
| Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer |
PHASE2 | UNKNOWN |
| A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung |
PHASE2 | COMPLETED |
| Biologic Correlative Taxotere/AC |
PHASE2 | COMPLETED |
| LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis |
PHASE2 | COMPLETED |
| Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage |
PHASE2 | RECRUITING |
| Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients |
PHASE2 | COMPLETED |
| Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. |
PHASE2 | RECRUITING |
| A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer |
PHASE2 | UNKNOWN |
| Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation |
PHASE2 | NOT_YET_RECRUITING |
| Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma |
PHASE2 | WITHDRAWN |
| Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. |
PHASE2 | COMPLETED |
| PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma |
PHASE2 | RECRUITING |
| The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. |
PHASE1/PHASE2 | COMPLETED |
| Pembrolizumab (MK-3475) in MM Patients With Residual Disease |
PHASE2 | COMPLETED |
| PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck |
PHASE1 | COMPLETED |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer |
PHASE1 | COMPLETED |
| Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery |
PHASE1 | COMPLETED |
| A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers |
PHASE1 | COMPLETED |
| A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma |
PHASE1 | COMPLETED |
| Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) |
PHASE1 | COMPLETED |
| Low Dose Melphalan and Bortezomib for AML and High-Risk MDS |
nan | COMPLETED |
| Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors |
nan | NOT_YET_RECRUITING |
| Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer |
nan | UNKNOWN |
| Establishment of Human Cellular Disease Models for Wilson Disease |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a FAU binder may also engage these)